Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Parkinson's Disease

Free Subscription Articles published in J Neurol Neurosurg Psychiatry Retrieve available abstracts of 63 articles: HTML format

Single Articles

November 2024
1. RAJALINGAM R, Sorrento G, Fasano A
   Risk of fall with device-based advanced treatments in Parkinson's disease: a systematic review and network meta-analysis.
   J Neurol Neurosurg Psychiatry. 2024 Nov 21:jnnp-2024-334521.
   PubMed     Abstract available
   
   
   September 2024
2. HVINGELBY V, Khalil F, Massey F, Hoyningen A, et al
   Directional deep brain stimulation electrodes in Parkinson's disease: meta-analysis and systematic review of the literature.
   J Neurol Neurosurg Psychiatry. 2024 Sep 20:jnnp-2024-333947.
   PubMed     Abstract available
   
   
   
3. RUSZ J, Dusek P, Tykalova T, Novotny M, et al
   Is speech function lateralised in the basal ganglia? Evidence from de novo Parkinson's disease.
   J Neurol Neurosurg Psychiatry. 2024 Sep 17:jnnp-2024-334297.
   PubMed     Abstract available
   
   
   August 2024
4. JERGAS H, Petry-Schmelzer JN, Hannemann JH, Thies T, et al
   One side effect: two networks? Lateral and posteromedial stimulation spreads induce dysarthria in subthalamic deep brain stimulation for Parkinson's disease.
   J Neurol Neurosurg Psychiatry. 2024 Aug 15:jnnp-2024-333434.
   PubMed     Abstract available
   
   
   July 2024
5. WOLFSCHLAG M, Cedergren Weber G, Weintraub D, Odin P, et al
   Impulse control disorders in Parkinson's disease: a national Swedish registry study on high-risk treatments and vulnerable patient groups.
   J Neurol Neurosurg Psychiatry. 2024 Jul 30:jnnp-2024-334116.
   PubMed     Abstract available
   
   
   
6. BOLIER E, Holewijn R, De Bie RMA, Beudel M, et al
   Validation of the hotspot for dorsolateral subthalamic nucleus targeting in deep brain stimulation surgery for Parkinson's disease: a post hoc analysis of a randomised controlled trial.
   J Neurol Neurosurg Psychiatry. 2024 Jul 20:jnnp-2023-333164.
   PubMed     Abstract available
   
   
   May 2024
7. PETKUS AJ, Donahue E, Jakowec MW, Bayram E, et al
   Data-driven sequence of cognitive decline in people with Parkinson's disease.
   J Neurol Neurosurg Psychiatry. 2024 May 30:jnnp-2023-333270.
   PubMed     Abstract available
   
   
   
8. GASCA-SALAS C, Pineda-Pardo JA, Del Alamo M, Jimenez T, et al
   Nigrostriatal blood-brain barrier opening in Parkinson's disease.
   J Neurol Neurosurg Psychiatry. 2024 May 17:jnnp-2023-332967.
   PubMed     Abstract available
   
   
   
9. JIANG S, Wang H, Yang C, Feng F, et al
   Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson's disease.
   J Neurol Neurosurg Psychiatry. 2024 May 9:jnnp-2023-332921.
   PubMed     Abstract available
   
   
   
10. ZHANG G, Yu H, Chen Y, Gong C, et al
    Neurophysiological features of STN LFP underlying sleep fragmentation in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2024 May 9:jnnp-2023-331979.
    PubMed     Abstract available
    
    
    April 2024
11. YIN Z, Yuan T, Yang A, Xu Y, et al
    Contribution of basal ganglia activity to REM sleep disorder in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2024 Apr 19:jnnp-2023-332014.
    PubMed     Abstract available
    
    
    
12. MAK JKL, McMurran CE, Hagg S
    Clinical biomarker-based biological ageing and future risk of neurological disorders in the UK Biobank.
    J Neurol Neurosurg Psychiatry. 2024;95:481-484.
    PubMed     Abstract available
    
    
    
13. BADENOCH JB, Paris A, Jacobs BM, Noyce AJ, et al
    Neuroanatomical and prognostic associations of depression in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2024 Apr 3:jnnp-2023-333007.
    PubMed     Abstract available
    
    
    March 2024
14. KIM R, Choi S, Kang N, Park K, et al
    Effects of high-intensity interval training and moderate-intensity continuous training on non-motor symptoms in patients with Parkinson's disease: a randomised pilot trial.
    J Neurol Neurosurg Psychiatry. 2024 Mar 28:jnnp-2023-331990.
    PubMed    
    
    
    
15. HONKANEN EA, Ronka J, Pekkonen E, Aaltonen J, et al
    GPi-DBS-induced brain metabolic activation in cervical dystonia.
    J Neurol Neurosurg Psychiatry. 2024;95:300-308.
    PubMed     Abstract available
    
    
    
16. 
    Correction: ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2024 Mar 5:jnnp-2016-315277.
    PubMed    
    
    
    February 2024
17. LANGESKOV-CHRISTENSEN M, Franzen E, Grondahl Hvid L, Dalgas U, et al
    Exercise as medicine in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2024 Feb 28:jnnp-2023-332974.
    PubMed     Abstract available
    
    
    
18. HOLEWIJN RA, Zoon TJC, Verbaan D, Bergfeld IO, et al
    Cognitive and psychiatric outcomes in the GALAXY trial: effect of anaesthesia in deep brain stimulation.
    J Neurol Neurosurg Psychiatry. 2024;95:214-221.
    PubMed     Abstract available
    
    
    January 2024
19. FAGGIANELLI F, Witjas T, Azulay JP, Benatru I, et al
    ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2024 Jan 25:jnnp-2023-332551.
    PubMed     Abstract available
    
    
    
20. SANDOVAL-INSAUSTI H, Flores-Torres MH, Bjornevik K, Cortese M, et al
    Flavonoid intake and risk of Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2024 Jan 24:jnnp-2023-332672.
    PubMed     Abstract available
    
    
    December 2023
21. GRONOSTAY A, Jost ST, Silverdale M, Rizos A, et al
    Stratifying quality of life outcome in subthalamic stimulation for Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2023 Dec 19:jnnp-2023-332272.
    PubMed     Abstract available
    
    
    
22. PAULO DL, Johnson GW, Doss DJ, Allen JH, et al
    Intraoperative physiology augments atlas-based data in awake deep brain stimulation.
    J Neurol Neurosurg Psychiatry. 2023;95:86-96.
    PubMed     Abstract available
    
    
    
23. YANG T, Xiao Y, Cheng Y, Huang J, et al
    Epigenetic clocks in neurodegenerative diseases: a systematic review.
    J Neurol Neurosurg Psychiatry. 2023;94:1064-1070.
    PubMed     Abstract available
    
    
    October 2023
24. AVENALI M, Zangaglia R, Cuconato G, Palmieri I, et al
    Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort.
    J Neurol Neurosurg Psychiatry. 2023 Oct 25:jnnp-2023-332387.
    PubMed     Abstract available
    
    
    
25. LI G, Huang P, Cui S, He Y, et al
    Effect of long-term Tai Chi training on Parkinson's disease: a 3.5-year follow-up cohort study.
    J Neurol Neurosurg Psychiatry. 2023 Oct 24:jnnp-2022-330967.
    PubMed     Abstract available
    
    
    September 2023
26. MARTINEZ FERNANDEZ R, Natera Villalba E, Rodriguez-Rojas R, Del Alamo M, et al
    Unilateral focused ultrasound subthalamotomy in early Parkinson's disease: a pilot study.
    J Neurol Neurosurg Psychiatry. 2023 Sep 6:jnnp-2023-331211.
    PubMed     Abstract available
    
    
    July 2023
27. PISANI S, Gosse L, Wieretilo R, Ffytche D, et al
    Cognitive and executive impairments in Parkinson's disease psychosis: a Bayesian meta-analysis.
    J Neurol Neurosurg Psychiatry. 2023 Jul 19:jnnp-2022-331028.
    PubMed     Abstract available
    
    
    
28. KIM R, Kang N, Byun K, Park K, et al
    Prognostic significance of peripheral neutrophils and lymphocytes in early untreated Parkinson's disease: an 8-year follow-up study.
    J Neurol Neurosurg Psychiatry. 2023 Jul 14:jnnp-2022-330394.
    PubMed     Abstract available
    
    
    
29. STEFANI A, Trenkwalder C, Arnulf I, Bliwise DL, et al
    Isolated rapid eye movement sleep behaviour disorder: clinical and research implications.
    J Neurol Neurosurg Psychiatry. 2023;94:581-582.
    PubMed    
    
    
    June 2023
30. JEONG SH, Park CJ, Jeong HJ, Sunwoo MK, et al
    Association of choroid plexus volume with motor symptoms and dopaminergic degeneration in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2023 Jun 30:jnnp-2023-331170.
    PubMed     Abstract available
    
    
    
31. NOJIMA I, Horiba M, Sahashi K, Koganemaru S, et al
    Gait-combined closed-loop brain stimulation can improve walking dynamics in Parkinsonian gait disturbances: a randomised-control trial.
    J Neurol Neurosurg Psychiatry. 2023 Jun 9:jnnp-2022-329966.
    PubMed     Abstract available
    
    
    
32. SINGH A, Cole RC, Espinoza AI, Wessel JR, et al
    Evoked mid-frontal activity predicts cognitive dysfunction in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2023 Jun 1:jnnp-2022-330154.
    PubMed     Abstract available
    
    
    May 2023
33. COSTELLO H, Yamamori Y, Reeves S, Schrag AE, et al
    Longitudinal decline in striatal dopamine transporter binding in Parkinson's disease: associations with apathy and anhedonia.
    J Neurol Neurosurg Psychiatry. 2023 May 23:jnnp-2022-330790.
    PubMed     Abstract available
    
    
    April 2023
34. HANNAWAY N, Zarkali A, Leyland LA, Bremner F, et al
    Visual dysfunction is a better predictor than retinal thickness for dementia in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2023 Apr 20:jnnp-2023-331083.
    PubMed     Abstract available
    
    
    February 2023
35. ALVES JN, Westner BU, Hojlund A, Weil RS, et al
    Structural and functional changes in the retina in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2023 Feb 17:jnnp-2022-329342.
    PubMed     Abstract available
    
    
    October 2022
36. DRAZICH-TAYLOR EHS, Todd E, Convery R, Bocchetta M, et al
    Q351R MAPT mutation is associated with a mixed 3R/4R tauopathy and a slowly progressive cognitive, behavioural and parkinsonian syndrome.
    J Neurol Neurosurg Psychiatry. 2022 Oct 13. pii: jnnp-2022-329330.
    PubMed    
    
    
    
37. KREMER NI, van Laar T, Lange SF, Statius Muller S, et al
    STN-DBS electrode placement accuracy and motor improvement in Parkinson's disease: systematic review and individual patient meta-analysis.
    J Neurol Neurosurg Psychiatry. 2022 Oct 7. pii: jnnp-2022-329192.
    PubMed     Abstract available
    
    
    September 2022
38. NG AS, Tan J, Ng E, Tay KY, et al
    Serum peroxiredoxin 3 is reduced in genetic carriers of Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2022 Sep 28. pii: jnnp-2022-329433.
    PubMed    
    
    
    
39. RIJKS N, Potters WV, Dilai J, De Bie RMA, et al
    Combining 7T T2 and 3T FGATIR: from physiological to anatomical identification of the subthalamic nucleus borders.
    J Neurol Neurosurg Psychiatry. 2022;93:1019-1020.
    PubMed    
    
    
    
40. WANG J, Chau SWH, Lam SP, Liu Y, et al
    Prevalence and correlates of REM sleep behaviour disorder in patients with major depressive disorder: a two-phase study.
    J Neurol Neurosurg Psychiatry. 2022;93:1010-1017.
    PubMed     Abstract available
    
    
    July 2022
41. KWON S, Jung SY, Han KD, Jung JH, et al
    Risk of Parkinson's disease in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide cohort study in South Korea.
    J Neurol Neurosurg Psychiatry. 2022 Jul 28. pii: jnnp-2022-329389.
    PubMed     Abstract available
    
    
    June 2022
42. LAWTON M, Tan MM, Ben-Shlomo Y, Baig F, et al
    Genetics of validated Parkinson's disease subtypes in the Oxford Discovery and Tracking Parkinson's cohorts.
    J Neurol Neurosurg Psychiatry. 2022 Jun 22. pii: jnnp-2021-327376.
    PubMed     Abstract available
    
    
    May 2022
43. XU SS, Lee WL, Perera T, Sinclair NC, et al
    Can brain signals and anatomy refine contact choice for deep brain stimulation in Parkinson's disease?
    J Neurol Neurosurg Psychiatry. 2022 May 19. pii: jnnp-2021-327708.
    PubMed     Abstract available
    
    
    
44. VIJIARATNAM N, Lawton M, Heslegrave AJ, Guo T, et al
    Combining biomarkers for prognostic modelling of Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2022 May 16. pii: jnnp-2021-328365.
    PubMed     Abstract available
    
    
    April 2022
45. LO C, Arora S, Lawton M, Barber T, et al
    A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2022 Apr 6. pii: jnnp-2021-327880.
    PubMed     Abstract available
    
    
    
46. WANG C, Chen F, Li Y, Liu J, et al
    Possible predictors of phenoconversion in isolated REM sleep behaviour disorder: a systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2022;93:395-403.
    PubMed     Abstract available
    
    
    March 2022
47. NAITO T, Satake W, Cha PC, Kobayashi K, et al
    Comparative whole transcriptome analysis of Parkinson's disease focusing on the efficacy of zonisamide.
    J Neurol Neurosurg Psychiatry. 2022 Mar 9. pii: jnnp-2021-328742.
    PubMed     Abstract available
    
    
    February 2022
48. TEKRIWAL A, Felsen G, Ojemann SG, Abosch A, et al
    Motor context modulates substantia nigra pars reticulata spike activity in patients with Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2022 Feb 22. pii: jnnp-2021-326962.
    PubMed     Abstract available
    
    
    December 2021
49. COSTELLO H, Berry AJ, Reeves S, Weil RS, et al
    Disrupted reward processing in Parkinson's disease and its relationship with dopamine state and neuropsychiatric syndromes: a systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2021 Dec 20. pii: jnnp-2021-327762.
    PubMed     Abstract available
    
    
    
50. STEINHARDT J, Hanssen H, Heldmann M, Neumann A, et al
    Sweets for my sweet: modulation of the limbic system drives salience for sweet foods after deep brain stimulation in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2021 Dec 15. pii: jnnp-2021-326280.
    PubMed     Abstract available
    
    
    
51. FAN FSY, Yip TCF, Yiu B, Lam B, et al
    Neurological diseases and risk of mortality in patients with COVID-19 and SARS: a territory-wide study in Hong Kong.
    J Neurol Neurosurg Psychiatry. 2021;92:1356-1358.
    PubMed    
    
    
    September 2021
52. ZARKALI A, McColgan P, Leyland LA, Lees AJ, et al
    Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2021 Sep 28. pii: jnnp-2021-326630.
    PubMed     Abstract available
    
    
    
53. SAUERBIER A, Loehrer P, Jost ST, Heil S, et al
    Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease.
    J Neurol Neurosurg Psychiatry. 2021 Sep 11. pii: jnnp-2021-326131.
    PubMed     Abstract available
    
    
    August 2021
54. LEE SH, Kim MS, Hwang YS, Jo S, et al
    Clinical implication of stimulation-induced dyskinaesia in globus pallidus deep brain stimulation for advanced Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2021 Aug 18. pii: jnnp-2020-326015.
    PubMed    
    
    
    March 2021
55. AKBAR U, McQueen RB, Bemski J, Carter J, et al
    Prognostic predictors relevant to end-of-life palliative care in Parkinson's disease and related disorders: a systematic review.
    J Neurol Neurosurg Psychiatry. 2021 Mar 31. pii: jnnp-2020-323939.
    PubMed     Abstract available
    
    
    February 2021
56. OLIVEIRA FPM, Walker Z, Walker RWH, Attems J, et al
    (123)I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease: a new quantitative analysis of autopsy confirmed cases.
    J Neurol Neurosurg Psychiatry. 2021 Feb 4. pii: jnnp-2020-324606.
    PubMed     Abstract available
    
    
    January 2021
57. LIN F, Wu D, Yu J, Weng H, et al
    Comparison of efficacy of deep brain stimulation and focused ultrasound in parkinsonian tremor: a systematic review and network meta-analysis.
    J Neurol Neurosurg Psychiatry. 2021 Jan 18. pii: jnnp-2020-323656.
    PubMed     Abstract available
    
    
    
58. LYU Z, Zheng S, Zhang X, Mai Y, et al
    Olfactory impairment as an early marker of Parkinson's disease in REM sleep behaviour disorder: a systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2021 Jan 12. pii: jnnp-2020-325361.
    PubMed     Abstract available
    
    
    December 2020
59. HALBGEBAUER S, Oeckl P, Steinacker P, Yilmazer-Hanke D, et al
    Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2020 Dec 30. pii: jnnp-2020-324306.
    PubMed     Abstract available
    
    
    
60. KAZMI H, Walker Z, Booij J, Khan F, et al
    Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson's disease: a cross-sectional study.
    J Neurol Neurosurg Psychiatry. 2020 Dec 2. pii: jnnp-2020-324266.
    PubMed     Abstract available
    
    
    
61. PHILLIPS O, D'Abreu A, Friedman JH, Akbar U, et al
    Recognising hemihypomimia as a mimic of 'facial weakness'.
    J Neurol Neurosurg Psychiatry. 2020;91:1357-1358.
    PubMed    
    
    
    October 2020
62. BAUMEISTER S, Meisinger C, Leitzmann M, Teumer A, et al
    Physical activity and Parkinson's disease: a two-sample Mendelian randomisation study.
    J Neurol Neurosurg Psychiatry. 2020 Oct 22. pii: jnnp-2020-324515.
    PubMed    
    
    
    May 2020
63. O'BRIEN J, Taylor JP, Ballard C, Barker RA, et al
    Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management.
    J Neurol Neurosurg Psychiatry. 2020;91:512-519.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.